文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

COVID-19大流行对克罗地亚医院抗菌药物消耗的影响

Impact of the COVID-19 pandemic on hospital antimicrobial consumption in Croatia.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

该研究基于2016至2020年欧洲抗菌药物消耗监测网络(ESAC-Net)报告的数据,评估COVID-19大流行对克罗地亚医院部门抗菌药物消耗(AMC)的影响。以DDD/1000居民/天和DDD/100住院日两种方式测量AMC,采用线性回归评估趋势,并计算大流行前年份的复合年增长率以预测2020年AMC并与实际消耗比较。结果显示2019至2020年医院AMC以DDD/1000居民/天计下降17%,以DDD/100住院日计则上升8%;5年间全身用抗菌药物医院消耗以DDD/1000居民/天计无显著变化,以DDD/100住院日计则统计学显著增加;广谱抗菌药物消耗呈增加趋势。结论认为大流行期间医院AMC增加且向广谱抗菌药物转移,需基于患者层面数据进一步深入定性分析;不同分母得出的对比结果表明DDD/1000居民/天指标对评估医院AMC不够敏感。

要点

  • 2019至2020年医院AMC以DDD/1000居民/天计下降17%,以DDD/100住院日计上升8%。
  • 5年间全身用抗菌药物医院消耗以DDD/1000居民/天计无显著变化,以DDD/100住院日计显著增加。
  • 广谱抗菌药物消耗呈增加趋势。

核心结论

  • 大流行期间医院AMC增加且向广谱抗菌药物转移,需基于患者层面数据进一步深入定性分析。
  • 不同分母得出的对比结果表明DDD/1000居民/天指标对评估医院AMC不够敏感。
  • 评估医院AMC时监测人群应与医疗背景相关,抗菌药物管理仍是应对抗菌药物耐药最重要的策略之一,抗菌药物监测方法必须尽可能敏感。

研究设计与样本

  • 研究分析2016至2020年报告至欧洲抗菌药物消耗监测网络(ESAC-Net)的数据,评估COVID-19大流行对克罗地亚医院部门抗菌药物消耗(AMC)的影响。
  • AMC以DDD/1000居民/天和DDD/100住院日两种方式测量;采用线性回归评估趋势,计算大流行前年份的复合年增长率以预测2020年AMC并与实际消耗比较。

主要发现

  • 2019至2020年医院AMC以DDD/1000居民/天计下降17%,以DDD/100住院日计上升8%。
  • 5年间全身用抗菌药物医院消耗以DDD/1000居民/天计无显著变化,以DDD/100住院日计统计学显著增加。
  • 发现广谱抗菌药物消耗呈增加趋势。

局限性

  • 需要基于患者层面数据进一步深入定性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of the study was to assess the impact of the COVID-19 pandemic on antimicrobial consumption (AMC) in the hospital sector in Croatia by analysing data reported to the European Surveillance of Antimicrobial Consumption Network (ESAC-Net) between 2016 and 2020. METHODS: AMC was measured as the number of DDDs/1000 inhabitants/day and as the number of DDDs/100 bed days. To assess trends, linear regression was performed. To assess the impact of the pandemic on AMC, the compound annual growth rate was calculated for the years preceding the pandemic based on which AMC for 2020 was forecasted and compared with the actual consumption. RESULTS: While hospital AMC expressed as DDDs/1000 inhabitants/day between 2019 and 2020 decreased by 17%, when expressed as DDDs/100 bed days, an 8% increase was observed. Hospital consumption of antibacterials for systemic use in the 5 year period did not significantly change when expressed as DDDs/1000 inhabitants/day, while it statistically significantly increased when expressed as DDDs/100 bed days. An increasing trend in consumption of broad-spectrum antimicrobials was found. CONCLUSIONS: During the pandemic there was an increase in hospital AMC with a shift towards broad-spectrum antimicrobials requiring further in-depth qualitative analysis based on patient-level data. Contrasting results obtained using different denominators indicate that the metric DDDs/1000 inhabitants/day is not sensitive enough to evaluate hospital AMC. When assessing hospital AMC, the population under surveillance should be relevant for healthcare context. Antimicrobial stewardship remains one of the most important strategies to tackle antimicrobial resistance and antimicrobial surveillance methods must be as sensitive as possible.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Vlahović-Palčevski V, Rubinić I, Payerl Pal M, et al. Impact of the COVID-19 pandemic on hospital antimicrobial consumption in Croatia. J Antimicrob Chemother. 2022. PMID: 35869875. doi:10.1093/jac/dkac247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。